 Home > Active Ingredient News > Drugs Articles > KPTI and Menarini Sign Exclusive License Agreement for Drug Commercialization

KPTI and Menarini Sign Exclusive License Agreement for Drug Commercialization

 Last Update: 2022-01-10
 Source: Internet
 Author: User

Tags

toradol oral dose

inc companies

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 23, 2021, Karyopharm Therapeutics Inc.

According to the terms of the agreement, Menarini will obtain the exclusive right to commercialize NEXPOVIO for the treatment of tumor indications in the European Union and European countries (including the United Kingdom), Latin America and other major countries

NEXPOVIO has obtained a conditional marketing authorization from the European Commission to treat adult patients with related multiple myeloma combined with dexamethasone, that is, they have received at least four previous therapies, and their disease uses at least two proteasome inhibitors and two immunizations The modulator and an anti-CD38 monoclonal antibody are incurable, and patients who showed progression of the disease in the last treatment

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Reta 5mg 10mg 15mg Vial Weight Loss Anti-diabetes Fat Loss

CAS No.: 2381089-83-2

Pharmacy Grade

$110-130/UNIT FOB

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Hot Sale 1-Adamantanamine Hydrochloride /1-Adamantanamine HCl CAS 665-66-7

CAS No.: 665-66-7

Pharmacy Grade

$20-25/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.